| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3084 | Ginsenoside Rg | Neuroprotective, anti-inflammatory, and anti-diabetic agent, protecting against DNA damage and apoptosis induced by ultraviolet light |
|
| DCC3085 | levormeloxifene Fumarate | Selective estrogen receptor modulator (SERM) |
|
| DCC3086 | Lfcinb6 | Hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin |
|
| DCC3087 | Lfs-829 | Novel potent and selective antagonist of exportin-1, attenuating dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice |
|
| DCC3088 | lg190178 | Novel non-secosteroidal vitamin D receptor (VDR) ligand |
|
| DCC3089 | Lgh00031 | Novel irreversible inhibitor of cell division cycle 25B, inhibiting human cancer cells via ROS generation |
|
| DCC3090 | Lgh447 Hydrochloride | Potent and specific pan-PIM inhibitor, inhibiting proliferation of several AML cell lines, showing dual antitumoral and bone antiresorptive effects |
|
| DCC3091 | Lh65.3 | Novel S. typhimurium infection inhibitor on the activity of DUSP3, DUSP11, and DUSP27 |
|
| DCC3092 | Lh-708 | Novel inhibitor of cystine stone formation for treatment of cystinuria |
|
| DCC3093 | L-histidinol Dihydrochloride | Natural precursor of histamine; reversible inhibitor of protein synthesis |
|
| DCC3094 | liafensine | Serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI); Anti-depressant |
|
| DCC3095 | liarozole Hydrochloride | Novel inhibitor of AMA1–RON2 interaction, blocking merozoite invasion from schizont-infected RBCs; Cytochrome P450 inhibitor |
|
| DCC3096 | Lifibrate | Inhibitor of cholinephosphotransferase (CPT), phosphatidyl-N-methylethanolamine N-methyltransferase (PME-NMT), and phosphatidyl-N,N-dimethylethanolamine N-methyltransferase (PDE-NMT) |
|
| DCC3097 | Liguzinediol | Potent positive inotropic agent, inhibiting myocardial cell apoptosis |
|
| DCC3098 | Lin28-let-7 Inhibitor-1 | Novel inhibitor of the oncogenic Lin28-let-7 interaction |
|
| DCC3099 | Linifolin A | Natural capsid inhibitor |
|
| DCC3100 | Linker-payload 49 | Novel Fused Benzodiazepine Hybrid Payload for Antibody-Drug Conjugate (ADC) |
|
| DCC3101 | Lintopride | 5HT-4 antagonist with moderate 5HT-3 antagonist properties |
|
| DCC3102 | Lipid Ii Binder 5107930 | Lipid II binder, causing specific upregulation of the vancomycin-resistance associated gene vraX which is implicated in the cell wall stress stimulon that confers glycopeptide resistance |
|
| DCC3103 | Lipocrine | The first inhibitor of the catalytic activity of AChE and AChE-induced amyloid-beta aggregation protecting against reactive oxygen species |
|
| DCC3104 | lisa-4 | The first fluorogenic dipeptide probe for |
|
| DCC3105 | Lith-o-asp | Novel pan-inhibitor of sialyltransferase (ST) |
|
| DCC3106 | Ljp-1586 | Potent, selective, and orally active inhibitor of semicarbazide-sensitive amine oxidase (SSAO) activity, inhibiting vascular adhesion protein 1 (VAP-1) activity and decreasing the density of macrophages in inflamed atherosclerotic plaques in mice |
|
| DCC3107 | lk 204-545 | Highly |
|
| DCC3108 | Lk-514 Featured | Novel selective agonist of the human melanocortin 1 receptor (hMC1R) for sunless tanning and prevention of genotoxicity of UV in melanocytes |
|
| DCC3109 | Ll4212 | Novel inducer of biofilm dispersal, having a slower rate of NO release |
|
| DCC3110 | Lm-030 | Novel inhibitor of kallikrein-related peptidase 7 (KLK7) and epidermal elastase 2 (ELA2) |
|
| DCC3111 | lm11a-24 | Novel Modulator of p75NTR-dependent motor neuron death |
|
| DCC3112 | lm11a-36 | Negative control for LM11A-24 |
|
| DCC3113 | Lm229 | Novel Probe for Imaging Tau Pathology in Transgenic Mouse and Rat Models |
|
